CUSIP 829401108COMSIONQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
100 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Ra Capital Management, L.P. | 9.91M | $407.49M | −540.3K | Reduced |
| 2 | Tpg Gp A, LLC | 6.74M | $277.49M | 0 | Held |
| 3 | Orbimed Advisors LLC | 3.56M | $146.53M | −143.3K | Reduced |
| 4 | Viking Global Investors LP | 3.20M | $131.45M |
| 0 |
| Held |
| 5 | Atlas Venture Life Science Advisors, LLC | 3.00M | $123.24M | −619.9K | Reduced |
| 6 | Enavate Sciences Gp, LLC | 2.48M | $101.95M | 0 | Held |
| 7 | Blackrock, Inc. | 1.29M | $53.14M | +447.0K | Added |
| 8 | Jpmorgan Chase & Co | 1.23M | $50.68M | −746.8K | Reduced |
| 9 | Vanguard Group Inc | 1.18M | $48.75M | +41.8K | Added |
| 10 | Perceptive Advisors LLC | 1.18M | $48.51M | 0 | Held |
See every fund holding Sionna Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders